hydiform8k09032008.htm


UNITED STATES
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
Washington, DC 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
 
 
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 

Date of Report (Date of earliest event reported)                  September 3, 2008
 
         Hydromer, Inc.
(Exact name of registrant as specified in its chapter)
 
 New Jersey
(State or other jurisdiction
of incorporation)
0-10683
(Commission
File Number)
22-2303576
(IRS Employer
Identification No.)

35 Industrial Parkway
Branchburg, N.J.
(Address of principal executive offices)
08876
(Zip Code)
 
   

Registrant's telephone number, including area code                (908) 722 – 5000
 
 
   

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

(  )  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

(  )  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

(  )  Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
(  )  Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240-13e-4(c))
 

 


 
- 1 -

 

 

 
 
Item 8.01. Other Events
 
Press Release Announcing a Coatings Services and Supply Agreement for Stent Placement Catheters with Medinol Ltd.
 

 
 
EXHIBIT INDEX
 
Exhibit No.                            Description of Exhibit

99.33                           Press Release issued September 3, 2008
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
- 2 -

SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
_______Hydromer, Inc._______
Registrant
 
_______/s/ Robert Y. Lee_______
Date __ September 3, 2008____
Robert Y. Lee
Chief Financial Officer
 

 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
- 3 -